Prasugrel versus ticagrelor in acute coronary syndrome: A randomized comparison

International Journal of Cardiology

Volumn 170, Issue 2, 2013, Pages

  Deharo, Pierre ^a,b   Bassez, Clemence ^a,b   Bonnet, Guillaume ^a,b   Pankert, Mathieu ^a,b   Quilici, Jacques ^a,b   Lambert, Marc ^a,b   Verdier, Valentine ^c   Morange, Pierre ^a,b   Alessi, Marie Christine ^a,b   Bonnet, Jean Louis ^a,b   Cuisset, Thomas ^a,b  

^a TIMONE HOSPITAL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

Acute coronary syndrome; Low on treatment platelet reactivity (LTPR); Prasugrel; Ticagrelor

Indexed keywords

PRASUGREL; TICAGRELOR;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; BLEEDING; COMPARATIVE EFFECTIVENESS; DIABETES MELLITUS; DOSE RESPONSE; DRUG SAFETY; HUMAN; LETTER; LOADING DRUG DOSE; PLATELET REACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOCYTE AGGREGATION; TREATMENT DURATION; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; LOW ON TREATMENT PLATELET REACTIVITY (LTPR); PRASUGREL; TICAGRELOR;

ACUTE CORONARY SYNDROME; ADENOSINE; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; THIOPHENES; TREATMENT OUTCOME;

EID: 84889094456     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.10.043     Document Type: Article

References (10)

1. S.R. Mehta, S. Yusuf, and R.J. Peters Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
2. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
3. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 36 2009 1045 1057
4. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), P.G. Steg, and S.K. James ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
5. T. Cuisset, G. Cayla, and C. Frere Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment? EuroIntervention 5 2009 325 329
6. T. Cuisset, B. Gaborit, and N. Dubois Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by Prasugrel maintenance therapy Int J Cardiol 168 1 2013 Sep 20 523 528
7. R. Mehran, S.V. Rao, and D.L. Bhatt Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium Circulation 123 2011 2736 2747
8. P. Deharo, C. Pons, and M. Pankert Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel after acute coronary syndrome: the POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study Int J Cardiol 168 2013 5004 5005
9. D. Alexopoulos, I. Xanthopoulou, and V. Gkizas Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction Circ Cardiovasc Interv 5 2012 797 804
10. G. Parodi, R. Valenti, and B. Bellandi Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study J Am Coll Cardiol 61 2013 1601 1606